Citation Impact
Citing Papers
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
2019 Science
Understanding Information Systems Continuance: An Expectation-Confirmation Model1
2001 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer
2004
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Engineering precision nanoparticles for drug delivery
2020 Standout
Urine markers for detection and surveillance of bladder cancer
2013
Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.
1995
Parkinson's disease
2021 Standout
Antecedent- and response-focused emotion regulation: Divergent consequences for experience, expression, and physiology.
1998 Standout
An epigenetic mechanism for capecitabine resistance in mesothelioma
2009
Implicit social cognition: Attitudes, self-esteem, and stereotypes.
1995 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human Non–Small-Cell Lung Cancer Cells
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
The dark side of self- and social perception: Black uniforms and aggression in professional sports.
1988
Head and neck cancer
2008 Standout
Drug development from marine natural products
2008 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Role congruity theory of prejudice toward female leaders.
2002 Standout
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
2002
Cancer genes and the pathways they control
2004 Standout
Sex bias in the naming of stimulus persons.
1993
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses
2003
Nasopharyngeal carcinoma
2015 Standout
Bladder cancer
2016 Standout
Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors
2005
Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity.
2009 Standout
Overview of the clinical efficacy of investigational anticancer drugs
2003
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Biomedicinals from the phytosymbionts of marine invertebrates: A molecular approach
2007
Resilient Individuals Use Positive Emotions to Bounce Back From Negative Emotional Experiences.
2004 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse
2018
Clinical Versus Actuarial Judgment
1989 StandoutScience
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma
2011
Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer
2005
Effect of Cardioactive Drugs on Action Potential Generation and Propagation in Embryonic Stem Cell-Derived Cardiomyocytes
2007
Advances in Malignant Mesothelioma
2005 Standout
Update on tubulin-binding agents
2005
The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
2009 StandoutNobel
Folate status and the safety profile of antifolates
2002
The need to belong: Desire for interpersonal attachments as a fundamental human motivation.
1995 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
2004
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Changing the world and changing the self: A two-process model of perceived control.
1982
Emotional Intelligence
1990 Standout
Current Data with Pemetrexed in Non–Small-Cell Lung Cancer
2003
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Organizational Information Systems: Determinants of Their Performance and Behavior
1982
Culture and the self: Implications for cognition, emotion, and motivation.
1991 Standout
Personal control and stress and coping processes: A theoretical analysis.
1984 Standout
Deindividuation and antinormative behavior: A meta-analysis.
1998
Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial
2005
Lipoplatin Formulation Review Article
2011
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Basking in reflected glory: Three (football) field studies.
1976 Standout
Attitude-behavior relations: A theoretical analysis and review of empirical research.
1977 Standout
The theory of planned behavior
1991 Standout
Unrequited love: On heartbreak, anger, guilt, scriptlessness, and humiliation.
1993
Illusion and well-being: A social psychological perspective on mental health.
1988 Standout
Including Mixtures in the Determination of Water Quality Criteria for Herbicides in Surface Water
2005
Habit and intention in everyday life: The multiple processes by which past behavior predicts future behavior.
1998 Standout
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
1998
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Ego depletion: Is the active self a limited resource?
1998 Standout
Standing out and standing in: The psychology of control in America and Japan.
1984 Standout
Transmission of attitude relevant information through a communication chain.
1974
Privacy and human behavior in the age of information
2015 StandoutScience
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Coping with stress during childhood and adolescence: Problems, progress, and potential in theory and research.
2001 Standout
The Challenge of Micropollutants in Aquatic Systems
2006 StandoutScience
Effects of similarity of fate on bad news transmission: A reexamination.
1974
Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery
2008
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Organizational Learning: The Contributing Processes and the Literatures
1991 Standout
Possible interference between tissue-non-specific alkaline phosphatase with an Arg54→Cys substitution and a counterpart with an Asp277→Ala substitution found in a compound heterozygote associated with severe hypophosphatasia
2000 StandoutNobel
Works of Robert D. Johnson being referenced
The allometric approach for interspecies scaling of pharmacokinetic parameters
1992
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
2001
Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval)
1999
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma
2001
Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule
2002
Improved detection of recurrent bladder cancer using the bard bta stat test
1997
Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer
2000
Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function
2006
Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.
2002
Deindividuation and valence of cues: Effects on prosocial and antisocial behavior.
1979
Preliminary results of a phase I study with MTA (LY231514) in combination with cisplatin in patients with solid tumors.
1999
Transamination is a Major Pathway of L-Dopa Metabolism following Peripheral Decarboxylase Inhibition
1974 Nature
Dose-response relationships between herbicides with different modes of action and growth of Lemna paucicostata: An improved ecotoxicological method
2004
Activities of alkaline phosphatase in first trimester chorion biopsy tissue
1985
Interactive effects of new valence and attraction on communicator behavior.
1973
Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin
1999
Effects of occupational choice and sex-role preferences on the attractiveness of competent men and women
1980